Clinical Trial Update: Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adjuvant nonavalent HPV vaccination in women treated for vulvar high-grade squamous intraepithelial lesions (HSIL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Disease
• Vulvar Hsil
• Vulvar Squamous Intraepithelial Lesion

Drugs mentioned

• Nonavalent HPV vaccine (HPV vaccine (nonavalent))

Snippet

Sponsor: Erasmus Medical Center | Conditions: Vulvar HSIL, HPV | Phase 4 | Status: NOT_YET_RECRUITING